301 related articles for article (PubMed ID: 27010944)
1. Imaging Mass Spectrometry Reveals Acyl-Chain- and Region-Specific Sphingolipid Metabolism in the Kidneys of Sphingomyelin Synthase 2-Deficient Mice.
Sugimoto M; Wakabayashi M; Shimizu Y; Yoshioka T; Higashino K; Numata Y; Okuda T; Zhao S; Sakai S; Igarashi Y; Kuge Y
PLoS One; 2016; 11(3):e0152191. PubMed ID: 27010944
[TBL] [Abstract][Full Text] [Related]
2. Sphingomyelin synthase 2 activity and liver steatosis: an effect of ceramide-mediated peroxisome proliferator-activated receptor γ2 suppression.
Li Y; Dong J; Ding T; Kuo MS; Cao G; Jiang XC; Li Z
Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1513-20. PubMed ID: 23640498
[TBL] [Abstract][Full Text] [Related]
3. Dynamic modification of sphingomyelin in lipid microdomains controls development of obesity, fatty liver, and type 2 diabetes.
Mitsutake S; Zama K; Yokota H; Yoshida T; Tanaka M; Mitsui M; Ikawa M; Okabe M; Tanaka Y; Yamashita T; Takemoto H; Okazaki T; Watanabe K; Igarashi Y
J Biol Chem; 2011 Aug; 286(32):28544-55. PubMed ID: 21669879
[TBL] [Abstract][Full Text] [Related]
4. Sphingomyelin synthase 2 is one of the determinants for plasma and liver sphingomyelin levels in mice.
Liu J; Zhang H; Li Z; Hailemariam TK; Chakraborty M; Jiang K; Qiu D; Bui HH; Peake DA; Kuo MS; Wadgaonkar R; Cao G; Jiang XC
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):850-6. PubMed ID: 19286635
[TBL] [Abstract][Full Text] [Related]
5. Sphingomyelin Synthase 2 Inhibition Ameliorates Cerebral Ischemic Reperfusion Injury Through Reducing the Recruitment of Toll-Like Receptor 4 to Lipid Rafts.
Xue J; Yu Y; Zhang X; Zhang C; Zhao Y; Liu B; Zhang L; Wang L; Chen R; Gao X; Jiao P; Song G; Jiang XC; Qin S
J Am Heart Assoc; 2019 Nov; 8(22):e012885. PubMed ID: 31718447
[TBL] [Abstract][Full Text] [Related]
6. All members in the sphingomyelin synthase gene family have ceramide phosphoethanolamine synthase activity.
Ding T; Kabir I; Li Y; Lou C; Yazdanyar A; Xu J; Dong J; Zhou H; Park T; Boutjdir M; Li Z; Jiang XC
J Lipid Res; 2015 Mar; 56(3):537-545. PubMed ID: 25605874
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the role of sphingomyelin synthase 2 in glucose metabolism in whole-body and peripheral tissues in mice.
Sugimoto M; Shimizu Y; Zhao S; Ukon N; Nishijima K; Wakabayashi M; Yoshioka T; Higashino K; Numata Y; Okuda T; Tamaki N; Hanamatsu H; Igarashi Y; Kuge Y
Biochim Biophys Acta; 2016 Aug; 1861(8 Pt A):688-702. PubMed ID: 27151272
[TBL] [Abstract][Full Text] [Related]
8. Epidermal permeability barrier function and sphingolipid content in the skin of sphingomyelin synthase 2 deficient mice.
Nomoto K; Itaya Y; Watanabe K; Yamashita T; Okazaki T; Tokudome Y
Exp Dermatol; 2018 Aug; 27(8):827-832. PubMed ID: 29345004
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of sphingomyelin synthase (SMS) affects intracellular sphingomyelin accumulation and plasma membrane lipid organization.
Li Z; Hailemariam TK; Zhou H; Li Y; Duckworth DC; Peake DA; Zhang Y; Kuo MS; Cao G; Jiang XC
Biochim Biophys Acta; 2007 Sep; 1771(9):1186-94. PubMed ID: 17616479
[TBL] [Abstract][Full Text] [Related]
10. Reducing plasma membrane sphingomyelin increases insulin sensitivity.
Li Z; Zhang H; Liu J; Liang CP; Li Y; Li Y; Teitelman G; Beyer T; Bui HH; Peake DA; Zhang Y; Sanders PE; Kuo MS; Park TS; Cao G; Jiang XC
Mol Cell Biol; 2011 Oct; 31(20):4205-18. PubMed ID: 21844222
[TBL] [Abstract][Full Text] [Related]
11. Sphingomyelin synthase SMS2 displays dual activity as ceramide phosphoethanolamine synthase.
Ternes P; Brouwers JF; van den Dikkenberg J; Holthuis JC
J Lipid Res; 2009 Nov; 50(11):2270-7. PubMed ID: 19454763
[TBL] [Abstract][Full Text] [Related]
12. [Sphingomyelin synthase 2 deficiency decreases atherosclerosis and inhibits inflammation in mice].
Qin R; Chen ML; Zhu K; Deng JB; Shi YY
Sheng Li Xue Bao; 2010 Aug; 62(4):333-8. PubMed ID: 20717634
[TBL] [Abstract][Full Text] [Related]
13. A Role for Ceramides, but Not Sphingomyelins, as Antagonists of Insulin Signaling and Mitochondrial Metabolism in C2C12 Myotubes.
Park M; Kaddai V; Ching J; Fridianto KT; Sieli RJ; Sugii S; Summers SA
J Biol Chem; 2016 Nov; 291(46):23978-23988. PubMed ID: 27703011
[TBL] [Abstract][Full Text] [Related]
14. Sphingomyelin synthase 2 deficiency inhibits the induction of murine colitis-associated colon cancer.
Ohnishi T; Hashizume C; Taniguchi M; Furumoto H; Han J; Gao R; Kinami S; Kosaka T; Okazaki T
FASEB J; 2017 Sep; 31(9):3816-3830. PubMed ID: 28522594
[TBL] [Abstract][Full Text] [Related]
15. Sphingomyelin synthase 2 loss suppresses steatosis but exacerbates fibrosis in the liver of mice fed with choline-deficient, L-amino acid-defined, high-fat diet.
Sugimoto M; Hamada T; Wakabayasi M; Yoshioka T; Kato H; Konishi H; Nagai R; Suzuki M; Numata Y; Igarashi Y; Yukioka H
Biochem Biophys Res Commun; 2020 Dec; 533(4):1269-1275. PubMed ID: 33059919
[TBL] [Abstract][Full Text] [Related]
16. Ceramide synthase 6 mediates sex-specific metabolic response to dietary folic acid in mice.
Barron K; Ogretmen B; Krupenko N
J Nutr Biochem; 2021 Dec; 98():108832. PubMed ID: 34358645
[TBL] [Abstract][Full Text] [Related]
17. A selective sphingomyelin synthase 2 inhibitor ameliorates diet induced insulin resistance
Huang Y; Huang T; Zhen X; Li Y; Mo M; Ye D; Cheng N
Pharmazie; 2019 Sep; 74(9):553-558. PubMed ID: 31484596
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization of enzymes catalyzing ceramide phosphoethanolamine biosynthesis in mice.
Bickert A; Ginkel C; Kol M; vom Dorp K; Jastrow H; Degen J; Jacobs RL; Vance DE; Winterhager E; Jiang XC; Dörmann P; Somerharju P; Holthuis JC; Willecke K
J Lipid Res; 2015 Apr; 56(4):821-35. PubMed ID: 25667419
[TBL] [Abstract][Full Text] [Related]
19. Regulation of glucose homeostasis and insulin action by ceramide acyl-chain length: A beneficial role for very long-chain sphingolipid species.
Montgomery MK; Brown SH; Lim XY; Fiveash CE; Osborne B; Bentley NL; Braude JP; Mitchell TW; Coster AC; Don AS; Cooney GJ; Schmitz-Peiffer C; Turner N
Biochim Biophys Acta; 2016 Nov; 1861(11):1828-1839. PubMed ID: 27591968
[TBL] [Abstract][Full Text] [Related]
20. Discovery and characterization of selective human sphingomyelin synthase 2 inhibitors.
Adachi R; Ogawa K; Matsumoto SI; Satou T; Tanaka Y; Sakamoto J; Nakahata T; Okamoto R; Kamaura M; Kawamoto T
Eur J Med Chem; 2017 Aug; 136():283-293. PubMed ID: 28505533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
